'Truly different': Roche's former hematology leader shifts a new Versant biotech into gear

Kyle LaHucik

Senior Reporter

While heading up the hematology unit at Roche/Genentech, Thomas Fuchs and his team “looked at everything” when trying to address the areas of unmet need …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

'Truly different': Roche's former hematology leader shifts a new Versant biotech into gear

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

'Tru­ly dif­fer­en­t': Roche's for­mer hema­tol­ogy leader shifts a new Ver­sant biotech in­to gear

Senior Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

'Truly different': Roche's former hematology leader shifts a new Versant biotech into gear